Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 79/100 | DilutionWatch score record |
| Shares Outstanding | 6.33M | Verified float table or market cache |
| Public Float | 1.63M | Verified float table or market cache |
| Market Cap | $14.50M | Market data cache |
| Cash Runway | 0.4 months | DilutionWatch score inputs |
| Shelf Capacity | $4.00M | SEC-derived dilution fields |
| ATM Capacity | $7.00M | SEC-derived dilution fields |
| Outstanding Warrants | 12.0K | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 7.
Recent SEC source mix: 424B3 1, EFFECT 3, S-1 1, XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
PPCB SEC Filing Activity — Last 12 Months
Shares outstanding reported by PPCB on the cover page of its latest 10-K/10-Q: 6.33M as of September 23, 2026.
DilutionWatch recorded 4 registration or prospectus documents for PPCB (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| S-1 | registration statement (IPO / follow-on) | 3 | Oct 05, 2026 |
| 424B3 | prospectus (resale / ATM) | 1 | Mar 06, 2026 |
| EFFECT | SEC declared a registration effective | 1 | Apr 21, 2026 |
| 10-K | annual report | 1 | Sep 25, 2026 |
| 10-Q | quarterly report | 1 | May 14, 2026 |
| 5 | annual insider ownership | 4 | Oct 21, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual PPCB Dilution Snapshot
Propanc Biopharma, Inc. (PPCB) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: October 27, 2026.
- Stored shelf registration capacity: $4.0M.
- Stored ATM program remaining capacity: $7.0M.
- Recent SEC activity tracked for PPCB: xbrl on 2026-09-25; xbrl on 2026-09-25; EFFECT on 2026-07-27.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
PPCB's DilutionScore is currently 79/100 (Critical risk), with 8 score changes tracked over 89 days. The score improved from 78/100 (Critical risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 27, 2026 | 79/100 | CRITICAL | 1 day |
| Oct 26, 2026 | 78/100 | CRITICAL | 1 day |
| Oct 20 – Oct 25, 2026 | 83/100 | CRITICAL | 6 days |
| Sep 28 – Oct 19, 2026 | 82/100 | CRITICAL | 22 days |
| Sep 24 – Sep 27, 2026 | 91/100 | CRITICAL | 4 days |
| Sep 14 – Sep 23, 2026 | 92/100 | CRITICAL | 10 days |
| Aug 22 – Sep 13, 2026 | 91/100 | CRITICAL | 23 days |
| Aug 14 – Aug 21, 2026 | 95/100 | CRITICAL | 7 days |
| Jul 30 – Aug 13, 2026 | 87/100 | CRITICAL | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
PPCB shares outstanding have decreased 0.0% from 15.86M (Mar 2026) to 15.86M (Mar 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| Mar 30, 2026 | 15.86M | 10.83M | ▲ 19.53% |
| Mar 23, 2026 | 15.86M | 9.06M | ▲ 26.87% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.